BDTX NASDAQ
Black Diamond Therapeutics, Inc.
1W: +0.5%
1M: -11.7%
3M: -4.1%
YTD: -24.1%
1Y: -49.2%
3Y: -34.4%
5Y: -79.7%
$1.89
+0.01 (+0.53%)
Weekly Expected Move ±5.0%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-03-19
Earliest Filing
2025-03-19
Latest Filing
partner: 1
Counterparties (Filed by BDTX)
1 relationshipsCompanies named in BDTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Servier Pharmaceuticals LLC | — | partner | Licensee granted worldwide rights to develop and commercialize BDTX-4933 | 2025-03-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-06-29 | Shareholder Vote | View | |
| 2026-05-21 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-16 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-03 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-19 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-03-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-07 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Other Events; Fi | View | |
| 2024-09-23 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-05-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-04-11 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-01-18 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR